Docoh
Loading...

NEXI Neximmune

GRANT
Utility
T cell compositions with improved phenotypic properties
18 May 21
The present invention provides an isolated cell composition, which in some embodiments is suitable for adoptive immunotherapy, as well as methods of manufacturing the cell compositions and methods of treatment with the cell compositions.
Mathias Oelke, Kristi Jones, Sojung Kim, Lauren Suarez, Ken Carter, Scott Carmer, Dan Bednarik, Vineetha Edavana, Emily Lu
Filed: 9 Dec 19
APP
Utility
Nanoparticle Compositions and Methods for Immunotherapy
23 Sep 20
The present invention provides compositions and methods for immunotherapy, which include shelf-stable pharmaceutical compositions for inducing antigen-specific T cells.
Bruce McCreedy
Filed: 17 Mar 20
APP
Utility
Production of Antigen-specific T-cells
16 Sep 20
The invention in various aspects provides for magnetic enrichment and/or expansion of antigen-specific T cells, allowing for identification and characterization of antigen-specific T cells and their T cell receptors (TCRs) for therapeutic and/or diagnostic purposes, as well as providing for production of antigen-specific engineered T cells for therapy.
Mathias OELKE, Jose Luis SANTOS, Sojung KIM, Jonathan SCHNECK, Alyssa KOSMIDES
Filed: 16 Mar 17
GRANT
Utility
Nanoparticle compositions and methods for immunotherapy
27 Apr 20
The present invention provides compositions and methods for immunotherapy, which include shelf-stable pharmaceutical compositions for inducing antigen-specific T cells.
Bruce McCreedy
Filed: 23 Dec 15
  • 1
Patents are sorted by USPTO publication date, most recent first